Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

CORRESPONDENCE- RESPONSE: Re: Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive Breast Cancer: Updated findings from NCIC CTG MA.17

Tu D, Pater JL, Ingle JN, Goss PE. CORRESPONDENCE- RESPONSE: Re: Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive Breast Cancer: Updated findings from NCIC CTG MA.17. J Natl Cancer Inst 2006; 98(16):1162-1163. 2006.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.